Nexgel (NXGL) Depreciation & Amortization (CF) (2018 - 2025)
Nexgel (NXGL) posted Depreciation & Amortization (CF) of $112000.0 for Q4 2025, down 0.88% on a QoQ basis from $113000.0 in Q3 2025, and up 3.7% year-over-year from $108000.0 in Q4 2024.
Nexgel (NXGL) Depreciation & Amortization (CF) (2018 - 2025) Analysis & Trends
Nexgel's Depreciation & Amortization (CF) history runs 8 years deep, the most recent figure standing at $112000.0 for Q4 2025.
- Quarterly Depreciation & Amortization (CF) rose 3.7% year-over-year to $112000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $450000.0 (up 3.21% YoY) and the FY2025 annual result came in at $450000.0, up 3.21% from the prior year.
- Depreciation & Amortization (CF) was $112000.0 for Q4 2025 at Nexgel, down from $113000.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $184000.0 in Q3 2024 and bottomed at -$93000.0 in Q4 2021.
- A 5-year average of $66850.0 and a median of $49500.0 in 2023 frame the typical range for Depreciation & Amortization (CF).
- Annual changes were most pronounced in 2021 — Depreciation & Amortization (CF) slumped 365.0% — and 2024, when it jumped 425.71%.
- Nexgel's Depreciation & Amortization (CF) stood at -$93000.0 in 2021, then soared by 130.11% to $28000.0 in 2022, then surged by 339.29% to $123000.0 in 2023, then fell by 12.2% to $108000.0 in 2024, then grew by 3.7% to $112000.0 in 2025.
- Business Quant data shows NXGL's Depreciation & Amortization (CF) at $112000.0 in Q4 2025, $113000.0 in Q3 2025, and $111000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | - |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 192.30 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 563.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 254.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 58.98 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 45.70 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 95.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 135.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 56.55 Mn |
| 10 | Nexgel | 3.50 Mn | 2.13 Mn | 819,000.00 | 112,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 112,000.00 |
| Dec 31, 2025 | 112,000.00 |
| Sep 30, 2025 | 113,000.00 |
| Sep 30, 2025 | 113,000.00 |
| Jun 30, 2025 | 111,000.00 |
| Jun 30, 2025 | 111,000.00 |
| Mar 31, 2025 | 114,000.00 |
| Mar 31, 2025 | 114,000.00 |
| Dec 31, 2024 | 108,000.00 |
| Dec 31, 2024 | 108,000.00 |
| Sep 30, 2024 | 184,000.00 |
| Sep 30, 2024 | 184,000.00 |
| Jun 30, 2024 | 82,000.00 |
| Jun 30, 2024 | 82,000.00 |
| Mar 31, 2024 | 62,000.00 |
| Mar 31, 2024 | 62,000.00 |
| Dec 31, 2023 | 123,000.00 |
| Dec 31, 2023 | 123,000.00 |
| Sep 30, 2023 | 35,000.00 |
| Sep 30, 2023 | 35,000.00 |